SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-4.27%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$501M
AUM Growth
+$501M
(+27%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
29.64%
Top 10 Holdings %
Top 10 Hldgs %
32.77%
Holding
285
New
86
Increased
57
Reduced
47
Closed
30
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$35.7M |
| 2 |
Biogen
BIIB
|
$22.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 4 |
Viatris
VTRS
|
$15.2M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$14.5M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$28.9M |
| 2 |
Merck
MRK
|
$17.9M |
| 3 |
Exxon Mobil
XOM
|
$14.8M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$10M |
| 5 |
Gevo
GEVO
|
$7.38M |
Sector Composition
| 1 | Healthcare | 64.78% |
| 2 | Energy | 5.21% |
| 3 | Technology | 2.24% |
| 4 | Materials | 2.17% |
| 5 | Consumer Discretionary | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
vTv Therapeutics
VTVT
$49.4M
| $1.05M | 0.04% |
+160,556
| New | +$1.05M |
|
|
ADYX
102
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $1.05M | 0.04% |
330,128
+180,128
| +120% | +$571K |
|
103
Rocket Pharmaceuticals
RCKT
$358M
| $1.03M | 0.04% |
+110,000
| New | +$1.03M |
|
104
Capricor Therapeutics
CAPR
$287M
| $1.01M | 0.04% |
250,450
-7,950
| -3% | -$32.2K |
|
105
Plus Therapeutics
PSTV
$45.7M
| $1M | 0.04% |
2,941,880
-2,422,220
| -45% | -$846K |
|
|
ARIA
106
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $987K | 0.04% |
169,000
+3,730
| +2% | +$21.8K |
|
107
BioCryst Pharmaceuticals
BCRX
$1.74B
| $985K | 0.04% |
+86,395
| New | +$985K |
|
108
Assertio
ASRT
$78M
| $943K | 0.04% |
+50,000
| New | +$943K |
|
|
ANAC
109
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $942K | 0.04% |
+8,000
| New | +$942K |
|
110
Natera
NTRA
$23B
| $939K | 0.04% |
+86,523
| New | +$939K |
|
|
HTWR
111
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $915K | 0.04% |
+17,500
| New | +$915K |
|
112
Champions Oncology
CSBR
$95.8M
| $893K | 0.04% |
+169,397
| New | +$893K |
|
|
ADXS
113
DELISTED
Advaxis, Inc.
ADXS
| $877K | 0.04% |
+85,700
| New | +$877K |
|
114
Microbot Medical
MBOT
$172M
| $856K | 0.04% |
2,039,122
-78,112
| -4% | -$32.6K |
|
|
CYNA
115
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $845K | 0.03% |
52,169
+32,866
| +170% | +$532K |
|
116
Neurogene
NGNE
$284M
| $844K | 0.03% |
+60,000
| New | +$844K |
|
117
Tonix Pharmaceuticals
TNXP
$243M
| $837K | 0.03% |
158,140
+129,114
| +445% | -$260K |
|
|
MNTA
118
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $821K | 0.03% |
+50,030
| New | +$821K |
|
|
RDUS
119
DELISTED
Radius Health, Inc.
RDUS
| $804K | 0.03% |
+11,600
| New | +$804K |
|
|
TSRO
120
DELISTED
TESARO, Inc.
TSRO
| $802K | 0.03% |
+20,000
| New | +$802K |
|
121
Aldeyra Therapeutics
ALDX
$350M
| $787K | 0.03% |
134,997
-131,956
| -49% | -$769K |
|
|
ZSPH
122
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $780K | 0.03% |
11,875
-2,973
| -20% | -$195K |
|
|
NURO
123
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $771K | 0.03% |
873,454
+74,515
| +9% | +$65.6K |
|
124
Cellectar Biosciences
CLRB
$15.3M
| $751K | 0.03% |
381,172
-189,208
| -33% | -$347K |
|
125
Strata Skin Sciences
SSKN
$7.84M
| $750K | 0.03% |
657,860
+203,508
| +45% | +$232K |
|